Methyl (7R,8S,9S,10R,11R,13S,14S,17R)-11-hydroxy-10,13-dimethyl-3,5'-dioxo-1,2,3,4',5',6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3'H-spiro[cyclopenta[a]phenanthrene-17,2'-furan]-7-carboxylate(CAS: 192704-56-6)

This compound is subject to the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) and is classified according to its physical and health hazards. Additionally, it falls under the European Union's Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) regulation. For FDA and EPA-related requirements, specific toxicity and environmental impact studies must be conducted and reported.

Alternatives include using different precursors or synthetic routes, such as employing methyl acetoacetate as a starting material or utilizing alternative functional groups that can be similarly derivatized. Isomers like the (7S,8R,9R,10S,11S,13R,14R,17S)-isomer can also be considered in some cases.

Research trends indicate a focus on its potential applications in medicinal chemistry and materials science. Market trends show increasing interest in its use as a precursor for developing new drugs and in the synthesis of advanced polymers. However, the overall market remains niche due to its complexity and specific applications.

Waste containing this compound should be collected in sealed containers and disposed of through professional chemical waste disposal services. Incineration is a common method for waste disposal, but proper environmental management is essential to prevent contamination. Always follow local and national regulations for hazardous waste disposal.